Yes, sounded good. NP was talking about plans, exactly our conversion here about focus on BLA, mono, cancer readouts. Around 2 min, he said the FDA requested more data with combo, which NP said they already have the data to give the FDA. Just guessing, but probably the 700mg data and maybe receptor occupancy data.